MITCHELL WALTERS: Open Payments
NPI 1477243228 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 31 payments from 15 companies in 2025. Trend: 2023 $105 · 2024 $527 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $146 |
| Ferring Pharmaceuticals Inc. | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $111 |
| ACCORD HEALTHCARE, INC. | 3 | $90 |
| Janssen Biotech, Inc. | 3 | $50 |
| Endo USA, Inc. | 2 | $41 |
| Calyxo, Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Dendreon Pharmaceuticals LLC | 1 | $28 |
Products named: XTANDI, ADSTILADRIN, Nubeqa, Camcevi, ERLEADA, CVAC ASPIRATION SYSTEM, PLUVICTO, ORGOVYX.
Industry payments across IN — which companies pay providers there.
